Mitochondrial Genomics of HIV Outcomes

The primary goals of my research are to: 1) expand our understanding of the role of genetic variation in mitochondrial DNA (mtDNA) in outcomes of HIV infection and treatments; and 2) to characterize relevant biomarkers of adverse outcomes in treated HIV-infected persons. This work includes collaborations with the AIDS Clinical Trials Group (ACTG), the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) group, and multi-disciplinary teams of investigators including clinical pharmacologists, biostatisticians, mitochondrial geneticists, and computational biologists/geneticists. My projects bridge epidemiology-outcomes and clinical-translational research domains.

Click here for more info

Todd Hulgan [Email]
Medicine, Infectious Diseases

South Africa; Thailand; Nashville, TN, USA; Multi-site US and global consortia

Contacts N/A
Program Type


Funding Type



Africa, Asia, North America

Global Health Topics

Epidemiology, HIV/AIDS, Infectious diseases


Graduate students (non-clinical); Medical students (MD); Post-doctoral students, residents, or trainees

Program Length

Flexible, depending on the individuals interests and needs

VU Affiliation

The program is affiliated with Vanderbilt.


The program does not have a language requirement.